Background: The data on mutation frequencies in patients with lung cancer are limited in Turkey. We aimed to determine the frequencies of EGFR, ALK, ROS1, and BRAF gene mutations in patients with lung cancer in this study. Materials and Methods: Data of 329 patients with lung cancer, who underwent molecular examination at the İstanbul Sultan 2.